Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: Sunitinib and bevacizumab are intracellular and extracellular inhibitor of vascular endothelial growth factor(VEGF) pathway respectively, the influence of both of which on the proliferation of neuroendocrine neoplasm (NEN) cell lines in vitro was not known yet.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author: Zhang Y
Authors: Zhang Y, Chen L, Lin Y, Chen M, Chen J,
Keywords: neuroendocrine neoplasm, sunitinib, bevacizumab, VEGF pathway,
#1179 A Phase II Study of Axitinib in Advanced Carcinoid Tumors: Preliminary Results
Introduction: NETs are highly vascularized neoplasms overexpressing VEGF as well as VEGFR. Axitinib is a TKI with selective picomolar potency against VEGFR-1, -2 and -3
Conference: 12th Annual ENETSConcerence (2015)
Presenting Author:
Authors: Cives M, Strosberg J, Campos T, Weber T, Nickerson M,
Keywords: axitinib, anti-angiogenesis, VEGFR,
Introduction: Clinical studies have suggested efficacy of VEGF pathway inhibitors in the treatment of advanced neuroendocrine tumors (NETs).
Conference: 11th Annual ENETSConcerence (2014)
Presenting Author: Qian Z
Authors: Qian Z, Ter-Minassian M, Chan J, Imamura Y, Hooshmand S,
Keywords: VEGF, bevacizumab, NET survival,